Northern Oak Wealth Management Inc. increased its stake in CVS Health Corp (NYSE:CVS) by 42.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,113 shares of the pharmacy operator’s stock after acquiring an additional 22,187 shares during the period. Northern Oak Wealth Management Inc.’s holdings in CVS Health were worth $6,027,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fieldpoint Private Securities LLC boosted its position in shares of CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the last quarter. Arcadia Investment Management Corp MI boosted its position in shares of CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock worth $108,000 after acquiring an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new stake in shares of CVS Health in the second quarter worth approximately $119,000. Captrust Financial Advisors acquired a new stake in shares of CVS Health in the second quarter worth approximately $155,000. Finally, Valeo Financial Advisors LLC acquired a new stake in shares of CVS Health in the third quarter worth approximately $159,000. 80.81% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts recently commented on the stock. Jefferies Group set a $86.00 price target on shares of CVS Health and gave the company a “hold” rating in a report on Wednesday, October 18th. Mizuho set a $90.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Tuesday, October 24th. Robert W. Baird restated a “hold” rating and issued a $77.00 price target on shares of CVS Health in a report on Friday, October 27th. Loop Capital restated a “hold” rating on shares of CVS Health in a report on Friday, October 27th. Finally, Cowen set a $86.00 price target on shares of CVS Health and gave the company a “buy” rating in a report on Sunday, October 29th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. CVS Health currently has an average rating of “Buy” and an average target price of $87.77.

In other news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the sale, the executive vice president now owns 15,556 shares in the company, valued at $1,166,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.61% of the company’s stock.

Shares of CVS Health Corp (NYSE CVS) opened at $69.39 on Monday. The stock has a market cap of $70,462.84, a P/E ratio of 11.72, a PEG ratio of 1.16 and a beta of 0.93. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.00. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.52 and a current ratio of 1.02.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.88 by $0.04. The company had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The business’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.71 earnings per share. sell-side analysts forecast that CVS Health Corp will post 6.47 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.88%. CVS Health’s dividend payout ratio is currently 30.91%.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corp (CVS) Shares Bought by Northern Oak Wealth Management Inc.” was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://theolympiareport.com/2018/02/12/cvs-health-corp-cvs-shares-bought-by-northern-oak-wealth-management-inc.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.